Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Life as a vaccinated close contact...
Where is Victoria's peak?
The vaccine is working! Here's how we can tell
Faster to lockdown - so why is the curve the same?
How are Australia's outbreaks tracking?
What does DIY COVID testing mean for the months ahead?
What can the world tell us about reopening?
Are vaccines better at preventing infection than we thought?
Is the path out of lockdowns a one-way street?
Is the NSW curve bending or flattening?
Why vaccinated people shouldn't have more freedoms (quite yet)
Even with high vaccination, we might need more ...
Moderna is coming! What is it again?
NSW's big (risky?) leap to reopening!
What might the next few weeks look like?
I know the vaccine will protect me, but will it protect others?
Why aren't more Indigenous people vaccinated?
Is it fair to wait to reopen until kids are vaccinated?
Boost me baby! Should we all actually have three doses?
Victoria gives up on donut days forever
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First